Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Return on Assets (2018 - 2025)

Historic Return on Assets for Dianthus Therapeutics (DNTH) over the last 7 years, with Q3 2025 value amounting to 0.28%.

  • Dianthus Therapeutics' Return on Assets fell 900.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.31% for FY2024, which is 300.0% up from last year.
  • As of Q3 2025, Dianthus Therapeutics' Return on Assets stood at 0.28%, which was down 900.0% from 0.34% recorded in Q2 2025.
  • In the past 5 years, Dianthus Therapeutics' Return on Assets ranged from a high of 0.14% in Q4 2022 and a low of 0.44% during Q2 2023
  • In the last 4 years, Dianthus Therapeutics' Return on Assets had a median value of 0.23% in 2023 and averaged 0.25%.
  • As far as peak fluctuations go, Dianthus Therapeutics' Return on Assets crashed by -2500bps in 2023, and later skyrocketed by 2900bps in 2024.
  • Over the past 4 years, Dianthus Therapeutics' Return on Assets (Quarter) stood at 0.14% in 2022, then tumbled by -61bps to 0.23% in 2023, then grew by 1bps to 0.23% in 2024, then decreased by -20bps to 0.28% in 2025.
  • Its Return on Assets stands at 0.28% for Q3 2025, versus 0.34% for Q2 2025 and 0.28% for Q1 2025.